Abatacept for severe anti-TNF-alfa refractory JIA-associated uveitis: one year follow-up

Documenti analoghi

• Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
  di: Alpigiani, MG, et al.
  Pubblicazione: (2008)
• PReS-FINAL-2092: Bone marrow cells (BMC) added to platelet-rich plasma (PRP) for treatment of bone degenerative processes in JIA patients: follow-up of 2 cases
  di: Salvati, P, et al.
  Pubblicazione: (2013)
• Pregnancy outcomes in women affected by juvenile idiopathic arthritis (JIA)
  di: Alpigiani, Maria Giannina, et al.
  Pubblicazione: (2014)
• Use of bone marrow cells (BMCS) added to Platelet-Rich Plasma (PRP) for treatment of bone degenerative processes in JIA patients: a case report
  di: Alpigiani, MG, et al.
  Pubblicazione: (2011)
• Juvenile idiopathic arthritis (JIA) and early diagnosis of temporo-mandibular joint (TMJ) disorders
  di: Alpigiani, MG, et al.
  Pubblicazione: (2008)